SNTA Financial Facts
Loss from operations: -14.09MResearch and development: 7.8M
See Full Income Statement
Accounts payable: 1.16M
Total liabilities and stockholders' equity: 41.51M
See Full Balance Sheet
Synta Pharma (SNTA) Earnings
|
Expand Research on SNTA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +13.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/5/15 | Q315 | -$0.13 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
8/6/15  |
 |
Q215 | -$0.15 | -$0.18 | +$0.03 | N/A | N/A | N/A | | | Details |
| 5/7/15 |
|
Q115 | -$0.19 | -$0.20 | +$0.01 | N/A | N/A | N/A | | | Details |
| 11/6/14 |
Q314 | -$0.19 | -$0.24 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 8/6/14 | Q214 | -$0.24 | -$0.27 | +$0.03 | N/A | $480M | N/A | | | Details | |
| 5/8/14 |
Q114 | -$0.28 | -$0.29 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 3/11/14 | Q413 | -$0.31 | -$0.30 | -$0.01 | N/A | $370K | N/A | | | Details | |
| 11/4/13 | Q313 | -$0.33 | -$0.31 | -$0.02 | N/A | N/A | N/A | | | Details |
